Inspiremd announces may 15th as new date for first quarter 2023 financial results and corporate business update

-conference call and webcast to be held at 8:30 a.m. edt- tel aviv, israel, may 05, 2023 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention stent system (eps) device for the treatment of carotid artery disease and stroke prevention, announced today it will now report first quarter 2023 financial results on monday, may 15th, 2023.
NSPR Ratings Summary
NSPR Quant Ranking